DHR Health Welcomes Dr. Lisa Brown

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -
Lisa Brown, M.D., joins DHR Health.

Edinburg, TX — DHR Health is pleased to welcome Lisa Brown, M.D., back to the Rio Grande Valley as a physician for DHR Health Hospice. Brown is Board Certified by the American Board of Family Medicine, the American Board of Family Medicine/Hospice and Palliative Medicine and the American Board of Family Medicine Geriatrics. 

Brown will join James Castillo, M.D., medical director of DHR Health Hospice, and the hospital’s palliative care team. The team is dedicated to improving the quality of life for patients who are terminally ill and have a life expectancy of less than six months. DHR Health Hospice provides continuous care along with emotional, physical and spiritual resources to patients and their family.

Raised in Mission, Texas, Brown completed medical school at Baylor College of Medicine in Houston, Texas.  She did a family medicine residency at Methodist Charlton Medical Center in Dallas, Texas and a fellowship in combined geriatric and hospice and palliative medicine at the University of Texas Health Science Center in San Antonio, Texas. 

- Advertisement -

For more information about the services offered at DHR Health Hospice, please call (956) 362-3780 or for services offered at DHR Health Palliative Care, please call (956) 720-4721 or visit our DHR Health website, www.dhrhealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -